Effect and mechanism of uPAR-derived peptide in reversing multi-drug resistance in human leukemia K562/ADM cells

Hong Guo,Shu-ling Zhang,Lan-xia Zhou,Yun-yun Ma,Fang Jia,Xin-xin Hu,Hui Zhang,Li Zhao
DOI: https://doi.org/10.13885/j.issn.1000-2812.2018.01.011
2018-01-01
Abstract:Objective To investigate its effect of the newly synthesized uPAR-derived peptide (RERF peptide) on leukemic K562/ADM and its mechanism.Methods The effect of RERF peptide on the proliferation of K562/ADM cells was observed by MTT assay.The reversal effect of non-cytotoxic dose of RERF peptide on drug resistance of adriamycin resistant K562/ADM cells was observed.The relative expression of uPA,uPAR and MDR1 gene in K562/ADM cells was detected by qPCR.And the expression of uPA,uPAR and P-gp protein in K562/ADM cells were detected by a western blot analysis.Results The IC50 values of K562/ADM cells were 92.48±0.27,30.99±0.19,28.06±0.12 μg/mL respectively at 24 h,48 h,and 72 h after ADM administration.The IC50 decreased to 83.83±0.29,18.52±0.17,16.38±0.13 μg/mL respectively at 24 h,48 h and 72 h after ADM combined with non-cytotoxic doses of RERF peptide.The expression of uPA,uPAR,MDR1 mRNA and p-gp protein in K562/ADM cells after treatment 48 h were significantly decreased (P < 0.05).Conclusion RERF peptide could partially reverse the drug resistance of ADM in K562/ADM cells and improve the sensitivity of ADM.RERF peptide could reverse the resistance by affecting MDR1 gene via the uPA/uPAR pathway and decrease the express of P-gp.
What problem does this paper attempt to address?